Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandra Belani

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Clinical Lung Cancer|December 10, 2003
Update on results of multifield conformal radiation therapy of non-small-cell lung cancer using multileaf collimated beamsAjay Bhatnagar, John C Flickinger, Sanjeev Bahri, et al.
IEEE Journal of Biomedical and Health Informatics|April 28, 2023
Forecasting User Interests Through Topic Tag Predictions in Online Health CommunitiesAmogh Subbakrishna Adishesha, Lily Jakielaszek, Fariha Azhar, et al.
Journal of Hematology & Oncology|July 29, 2009
Vorinostat in solid and hematologic malignanciesDavid Siegel, Mohamad Hussein, Chandra Belani, et al.
European Urology Focus|July 30, 2017
Molecular Characterization of Bladder Cancer in Smokers versus NonsmokersMonika Joshi, Sherri Z Millis, David Arguello, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 5, 2005
Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidatesHiran C Fernando, Alberto De Hoyos, Rodney J Landreneau, et al.
Cancer|April 23, 2013
Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgeryJohn Varlotto, Achilles Fakiris, John Flickinger, et al.
Journal of Applied Clinical Medical Physics|March 2, 2005
Dosimetric uncertainties of three-dimensional dose reconstruction from two-dimensional data in a multi-institutional studyRebecca Weinberg, Darryl G L Kaurin, Hak Choy, et al.
Cancer Chemotherapy and Pharmacology|September 23, 2011
An open-label study to describe pharmacokinetic parameters of erlotinib in patients with advanced solid tumors with adequate and moderately impaired hepatic functionCindy L O'Bryant, Paul Haluska, Lee Rosen, et al.
Clinical Lung Cancer|July 26, 2022
A Review of Concurrent Chemo/Radiation, Immunotherapy, Radiation Planning, and Biomarkers for Locally Advanced Non-small Cell Lung Cancer and Their Role in the Development of ECOG-ACRIN EA5181John Michael Varlotto, Zhuoxin Sun, Bonnie Ky, et al.
The Oncologist|February 17, 2021
A Review of Immunotherapy for Stage III and Metastatic Non-Small Cell Lung Cancer and the Rationale for the ECOG-ACRIN EA5181 StudyJohn M Varlotto, Zhuoxin Sun, Bonnie Ky, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Clinical Lung Cancer|December 10, 2003
Update on results of multifield conformal radiation therapy of non-small-cell lung cancer using multileaf collimated beamsAjay Bhatnagar, John C Flickinger, Sanjeev Bahri, et al.
IEEE Journal of Biomedical and Health Informatics|April 28, 2023
Forecasting User Interests Through Topic Tag Predictions in Online Health CommunitiesAmogh Subbakrishna Adishesha, Lily Jakielaszek, Fariha Azhar, et al.
Journal of Hematology & Oncology|July 29, 2009
Vorinostat in solid and hematologic malignanciesDavid Siegel, Mohamad Hussein, Chandra Belani, et al.
European Urology Focus|July 30, 2017
Molecular Characterization of Bladder Cancer in Smokers versus NonsmokersMonika Joshi, Sherri Z Millis, David Arguello, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 5, 2005
Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidatesHiran C Fernando, Alberto De Hoyos, Rodney J Landreneau, et al.
Cancer|April 23, 2013
Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgeryJohn Varlotto, Achilles Fakiris, John Flickinger, et al.
Journal of Applied Clinical Medical Physics|March 2, 2005
Dosimetric uncertainties of three-dimensional dose reconstruction from two-dimensional data in a multi-institutional studyRebecca Weinberg, Darryl G L Kaurin, Hak Choy, et al.
Cancer Chemotherapy and Pharmacology|September 23, 2011
An open-label study to describe pharmacokinetic parameters of erlotinib in patients with advanced solid tumors with adequate and moderately impaired hepatic functionCindy L O'Bryant, Paul Haluska, Lee Rosen, et al.
Clinical Lung Cancer|July 26, 2022
A Review of Concurrent Chemo/Radiation, Immunotherapy, Radiation Planning, and Biomarkers for Locally Advanced Non-small Cell Lung Cancer and Their Role in the Development of ECOG-ACRIN EA5181John Michael Varlotto, Zhuoxin Sun, Bonnie Ky, et al.
The Oncologist|February 17, 2021
A Review of Immunotherapy for Stage III and Metastatic Non-Small Cell Lung Cancer and the Rationale for the ECOG-ACRIN EA5181 StudyJohn M Varlotto, Zhuoxin Sun, Bonnie Ky, et al.
Pageof 3